Page 14 - Population Sciences News Today

Bringing Taiwan to the World and the World to Taiwan

The Biden administration announced Monday it’s launching a new initiative to improve cancer outcomes in low-income communities. The administration is funneling $50 million to the new effort, dubbed the Persistent Poverty Initiative, which will be evenly distributed to five cancer research centers with the goal of addressing the “structural and institutional factors of persistent poverty”…

The U.S. administration launched a new initiative on Monday to alleviate the cumulative effects of persistent poverty on cancer outcomes,...

The administration awarded $50 million to launch the Persistent Poverty Initiative to alleviate the effects of persistent poverty on cancer outcomes.

LOS ANGELES, June 26 (Xinhua) -- The U.S. administration launched a new initiative on Monday to alleviate the cumulative effects of persistent poverty on cancer outcomes.

Doctors, researchers, nutritionists and activists have written to the World Health Organization and other medical institutions opposing the lowering of the minimum haemoglobin levels to diagnose anaemia in India. This comes after the disease was removed from the National Family Health Survey this year. The letter argues that lowering the levels will lead to an underestimation of anaemia in the country and the absence of a standard for international comparison. The medical implications of untreat...

/PRNewswire/ -- Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs to treat breast cancer....

Patients with depression and/or anxiety prior to a diagnosis of diffuse large B-cell lymphoma had shorter survival times than patients without a mental health diagnosis.

Population growth has long been a source of worry in India, which now has more people than China: 1.46 billion residents. But some experts are optimistic about the impact of this population boom.

Newly published data indicates that widely available medications for chronic lymphocytic leukemia (CLL) have steadily improved overall survival rates over most of the past three decades.